, South Korea
/Andrea De Santis from Unsplash

South Korea's capital adequacy rises to 232.2%

This was an increase of 8.1 percentage points from three months prior.

The capital adequacy ratios of South Korea’s domestic insurance companies under K-ICS, including transitional measures, were 232.2% at the end of December 2023.

This was an increase of 8.1 percentage points from 224.1% three months earlier. 

The ratio for life insurance companies rose by 8.4 percentage points to 232.8%, whilst nonlife insurers' ratio increased by 7.6 percentage points to 231.4%. 

Without transitional measures, the ratios were 214.0% at year-end 2023, up 12.2 percentage points from 201.8%. 

ALSO READ: Overseas ventures of South Korean insurers post mixed results in FY’23

Life insurers' ratios increased by 12.8 percentage points to 208.7%, and nonlife insurers' ratios rose by 11.3 percentage points to 221.9%.

Available capital under K-ICS was KRW261.6t at year-end 2023, a decrease of KRW 0.1t from three months earlier. 

Year-end dividend payments of KRW3.5t and a KRW6.4t decrease in accumulated other comprehensive income contributed to this reduction. 

Required capital decreased by KRW4.1t to KRW112.t, largely due to a KRW13.0t reduction in life/long-term insurance risk, as improved mass-lapse risk calculations reduced lapse risk by KRW21.5t.

Follow the link s for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.